GO: 6 × 0.5 g + 6 × 0.25 g of IVMP on a weekly schedule vs.
GO: 14
0
0
Lack of ALI criterion. Patients with AST and/or ALT above the upper limit—40 U/L. Comparison of the effect of total GCs between the two groups of patients including those with prednisolone therapy.
DON: 3 × 1.0 g of IVMP on consecutive days in the first week, repeated during the second week, followed by oral prednisolone in a tapering dose; CD of steroids 8.45 g
GO and DON: 1 g/d of IVMP for 3 consecutive days/week, repeated for 3–6 cycles, followed by a tapering dose of oral prednisolone. The daily dose of MP was reduced to 0.5 g except in cases with DON
GO and DON: 175
Mild 62 (35%),
0
ALT increase—mild (40–100 U/L), moderate (100–300 U/L), severe (>300 U/L)